pentoxifylline

Ukraine

Drugs containing this active substance

  • LATREN

    The drug is used to treat circulatory disorders caused by atherosclerosis, diabetes mellitus, inflammation, or venous disorders (e.g., in cases of trophic ulcers or gangrene). It is also prescribed for ischemic stroke, encephalopathy, Raynaud's disease, and circulatory disorders in the eye or inner ear.

    Form: solution for infusion

    Active substance Dosage
    pentoxifylline 0.5 mg/ml

    ATC: C04AD03

    Manufacturer: Yuria-Pharm LLC

  • The drug is used to treat circulatory disorders, such as atherosclerotic encephalopathy, ischemic stroke, circulatory disorders in the eyes or inner ear, as well as trophic disorders (e.g., ulcers or gangrene), Raynaud's disease, and other vascular problems.

    Form: solution for injection

    Active substance Dosage
    pentoxifylline 20 mg/ml

    ATC: C04AD03

    Manufacturer: KRKA, d.d., Novo mesto

  • The drug is prescribed to improve blood circulation in atherosclerotic encephalopathy, ischemic stroke, peripheral circulation disorders (due to diabetes or atherosclerosis), trophic disorders (ulcers, gangrene), Raynaud's disease, as well as in cases of circulatory disorders in the eye or the inner ear.

    Form: solution for infusion

    Active substance Dosage
    pentoxifylline 0.5 mg/ml

    ATC: C04AD03

    Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»

  • The drug is used to improve blood circulation in atherosclerotic encephalopathy, ischemic stroke, peripheral circulation disorders (e.g., in diabetes mellitus or Raynaud's disease), as well as in tissue trophic disorders, and visual and hearing impairments caused by vascular problems.

    Form: solution for injection

    Active substance Dosage
    pentoxifylline 20 mg/ml

    ATC: C04AD03

    Manufacturer: Yuria-Pharm LLC

  • The drug is prescribed to improve blood circulation in atherosclerotic encephalopathy, ischemic stroke, peripheral circulation disorders (due to diabetes or atherosclerosis), trophic disorders (ulcers, gangrene), Raynaud's disease, as well as circulatory disorders in the eye or the inner ear.

    Form: solution for injection

    Active substance Dosage
    pentoxifylline 20 mg/ml

    ATC: C04AD03

    Manufacturer: Subsidiary "Farmatreyd"

  • The drug is used for circulatory disorders caused by atherosclerosis, diabetes mellitus, or inflammation. It is prescribed for ischemic stroke, encephalopathies, Raynaud's disease, circulatory disorders in the eye or inner ear, as well as for trophic tissue disorders (e.g., gangrene or ulcers).

    Form: tablets, enteric-coated

    Active substance Dosage
    pentoxifylline 100 mg

    ATC: C04AD03

    Manufacturer: PJSC "Tekhnolog"

  • The drug is prescribed for circulatory disorders caused by atherosclerosis, diabetes mellitus, or inflammation. It is used in ischemic stroke, encephalopathy, Raynaud's disease, circulatory disorders in the eye or inner ear, as well as in trophic tissue disorders (e.g., ulcers or gangrene).

    Form: tablets

    Active substance Dosage
    pentoxifylline 200 mg

    ATC: C04AD03

    Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»

  • The drug is prescribed for circulatory disorders caused by atherosclerosis, diabetes mellitus, or inflammation. It is used in ischemic stroke, encephalopathies, angioneuropathy (Raynaud's disease), circulatory disorders in the eye or inner ear, as well as in trophic disorders (ulcers, gangrene) and obliterating endarteritis.

    Form: solution for injection

    Active substance Dosage
    pentoxifylline 20 mg/ml

    ATC: C04AD03

    Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»

  • The drug is prescribed for circulatory disorders caused by atherosclerosis, diabetes mellitus, or inflammation. It is used in ischemic stroke, encephalopathy, Raynaud's disease, circulatory disorders in the eye or inner ear, as well as for trophic tissue disorders (e.g., ulcers or gangrene).

    Form: tablets

    Active substance Dosage
    pentoxifylline 100 mg

    ATC: C04AD03

    Manufacturer: LLC "Corporation "Zdorovya"

  • The drug is prescribed for circulatory disorders (due to atherosclerosis, diabetes mellitus, or inflammation), ischemic stroke, encephalopathy, trophic disorders (ulcers, gangrene), Raynaud's disease, as well as circulatory disorders in the eye or the inner ear.

    Form: solution for injection

    Active substance Dosage
    pentoxifylline 20 mg/ml

    ATC: C04AD03

    Manufacturer: LLC "Corporation "Zdorovya"

  • The drug is used for atherosclerotic encephalopathy, ischemic stroke, peripheral circulation disorders (due to atherosclerosis, diabetes mellitus, or inflammation), trophic disorders (ulcers, gangrene, frostbite), Raynaud's disease, as well as circulatory disorders in the eye or the inner ear.

    Form: solution for injection

    Active substance Dosage
    pentoxifylline 20 mg/ml

    ATC: C04AD03

    Manufacturer: PJSC "Infuziya"

  • The drug is used to treat circulatory disorders caused by atherosclerosis, diabetes mellitus, or inflammation. It is prescribed for ischemic stroke, encephalopathy, Raynaud's disease, circulatory disorders in the eye or inner ear, as well as for trophic disorders (ulcers, gangrene, frostbite).

    Form: solution for infusion

    Active substance Dosage
    pentoxifylline 0.5 mg/ml

    ATC: C04AD03

    Manufacturer: PJSC "Infuziya"

  • The drug is prescribed to increase pain-free walking distance in patients with chronic occlusive peripheral arterial disease (intermittent claudication), if other treatment methods are impossible or not indicated.

    Form: tablets, extended-release

    Active substance Dosage
    pentoxifylline 400 mg

    ATC: C04AD03

    Manufacturer: KRKA, d.d., Novo mesto

  • The drug is used to treat circulatory disorders, such as atherosclerotic encephalopathy, ischemic stroke, circulatory disorders in the eyes or inner ear, as well as problems with peripheral circulation (e.g., in diabetes mellitus, Raynaud's disease, or trophic tissue disorders).

    Form: solution for injection

    Active substance Dosage
    pentoxifylline 20 mg/ml

    ATC: C04AD03

    Manufacturer: Pharmasel LLC (full cycle)

  • The drug is used to increase pain-free walking distance in chronic peripheral arterial disease (intermittent claudication). It is also prescribed for circulatory disorders that cause inner ear dysfunction (e.g., hearing loss or sudden deafness).

    Form: tablets, film-coated, retard

    Active substance Dosage
    pentoxifylline 600 mg

    ATC: C04AD03

    Manufacturer: G.L. Pharma GmbH